Research shows: Traditional Chinese medicine provides new options to combat certain types of "superbugs."

Due to limited treatment options and high mortality rates, multidrug-resistant Gram-negative bacterial pneumonia has become a challenge threatening patients' lives. Chinese medicine scholars in our country have found that traditional Chinese medicine can be a new option to combat these "superbugs" after more than two years of clinical trials. On the 24th, reporters learned from the Guang'anmen Hospital of the China Academy of Chinese Medical Sciences that the team led by Chief Physician Qi Wensheng discovered that the traditional Chinese medicine compound Xinjia Dayuan San showed statistically significant advantages in improving the microbiological clearance rate by day 7. The related results were published online in the international journal "Phytomedicine." The study indicates that the clinical benefits of Xinjia Dayuan San are associated with a significant reduction in key pro-inflammatory cytokines. Third-party experts believe that this finding provides patients with an auxiliary treatment option and further proves the unique role of traditional Chinese medicine in treating certain difficult diseases that threaten human health